Cargando…

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease

Previous research has investigated whether hyperuricemia serves as an independent risk factor for cardiovascular and renal diseases. Hyperuricemia is defined as an abnormally high level of uric acid (UA; i.e., serum urate level > 6.8 mg/dL). Hyperuricemia has been considered a complication of chr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waheed, Yousuf, Yang, Fan, Sun, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588983/ https://www.ncbi.nlm.nih.gov/pubmed/33045808 http://dx.doi.org/10.3904/kjim.2020.340

Ejemplares similares

To treat or not to treat asymptomatic hyperuricemia in chronic kidney disease
por: Shin, Dong Ho
Publicado: (2019)

Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
por: Eleftheriadis, Theodoros, et al.
Publicado: (2017)

Urate-lowering agents for asymptomatic hyperuricemia in stage 3 – 4 chronic kidney disease: Controversial role of kidney function
por: Jeon, Hee Jung, et al.
Publicado: (2019)

Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey
por: Cha, Ran-hui, et al.
Publicado: (2019)

The role of roxadustat in chronic kidney disease patients complicated with anemia
por: Liu, Jie, et al.
Publicado: (2023)

Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
por: Ramirez, Maria Erika G., et al.
Publicado: (2017)

Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy
por: Lee, Tao Han, et al.
Publicado: (2021)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013)

Associations Between Hyperuricemia and Chronic Kidney Disease: A Review
por: Prasad Sah, Om Shankar, et al.
Publicado: (2015)

Hyperuricemia and chronic kidney disease: to treat or not to treat
por: Piani, Federica, et al.
Publicado: (2021)

The grey zone of Hyperuricemia in chronic kidney disease
por: Dousdampanis, Periklis
Publicado: (2017)

Role of febuxostat in retarding progression of diabetic kidney disease with asymptomatic hyperuricemia: A 6-months open-label, randomized controlled trial
por: Mukri, Mohd Noor Azreey, et al.
Publicado: (2018)

Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease
por: Yanai, Hidekatsu, et al.
Publicado: (2021)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
por: Akimoto, Tetsu, et al.
Publicado: (2014)

Hyperuricemia: A non-traditional risk factor for development and progression of chronic kidney disease?
por: Kang, Duk-Hee
Publicado: (2012)

Hyperuricemia Predicts the Progression of Type 2 Diabetic Kidney Disease in Chinese Patients
por: Zhu, Lin, et al.
Publicado: (2023)

Changeover Trial of Febuxostat and Topiroxostat for Hyperuricemia with Cardiovascular Disease: Sub-Analysis for Chronic Kidney Disease (TROFEO CKD Trial)
por: Sezai, Akira, et al.
Publicado: (2019)

Joint association of hyperuricemia and chronic kidney disease with mortality in patients with chronic heart failure
por: Wang, Chi, et al.
Publicado: (2023)

Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities
por: Wu, Junnan, et al.
Publicado: (2017)

Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease
por: Yang, Letian, et al.
Publicado: (2022)

Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice
por: Gaubert, Mélanie, et al.
Publicado: (2020)

Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease
por: Visconti, Luca, et al.
Publicado: (2016)

Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study
por: Kawashima, Masatoshi, et al.
Publicado: (2011)

Effect of Urate-Lowering Therapy on the Progression of Kidney Function in Patients With Asymptomatic Hyperuricemia: A Systematic Review and Meta-Analysis
por: Zhang, Lin, et al.
Publicado: (2022)

Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
por: Zhang, Yannan, et al.
Publicado: (2018)

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets
por: Lim, Yong Jin, et al.
Publicado: (2021)

Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
por: Kielstein, Jan T., et al.
Publicado: (2020)

Association between Dietary Fat Intake and Hyperuricemia in Men with Chronic Kidney Disease
por: Oku, Fumika, et al.
Publicado: (2022)

Alterations of gut microbiota and metabolome in early chronic kidney disease patients complicated with hyperuricemia
por: Liu, Ping, et al.
Publicado: (2023)

Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?
por: Gaffo, Angelo L, et al.
Publicado: (2009)

Cardiovascular disease in patients with chronic kidney disease
por: Wright, Julian, et al.
Publicado: (2009)

Cardiovascular Disease in Diabetes and Chronic Kidney Disease
por: Swamy, Sowmya, et al.
Publicado: (2023)

Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications
por: Anders, Hans-Joachim, et al.
Publicado: (2023)

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
por: Rysz, Jacek, et al.
Publicado: (2020)

Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
por: Stenvinkel, Peter, et al.
Publicado: (2021)

The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation
por: Maloberti, Alessandro, et al.
Publicado: (2023)

Hyperuricemia and Cardiovascular Risk
por: Shahin, Lauren, et al.
Publicado: (2021)

Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study
por: Watanabe, Kimio, et al.
Publicado: (2021)

Hyperuricemia and Associated Factors in Children with Chronic Kidney Disease: A Cross-Sectional Study
por: Xu, Jie, et al.
Publicado: (2021)

Determinants of hyperuricemia in non-dialysed chronic kidney disease patients in three hospitals in Cameroon
por: Doualla, Marie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_chqjjbbol4nhjm0dcgql3u9gkv